Sygenus
Chronic Wound Healing
Phase 1Active
Key Facts
About Cambium Bio
Australian‑based regenerative biotech advancing platelet‑lysate and MSC‑based therapies for eye, joint and wound indications.
View full company profileTherapeutic Areas
Other Chronic Wound Healing Drugs
| Drug | Company | Phase |
|---|---|---|
| SofPulse® | Endonovo Therapeutics | Commercial |